- Active (497)
- Anti-irritant (118)
- Antimicrobial (96)
- Antioxidant (22)
- Colorant/Pigment/Hair Dye (100)
- Conditioner/Moisturizer (261)
- Delivery (161)
- Exfoliant (13)
- Feel Enhancer (184)
- Film-former (15)
- Formulating Aids (135)
- Fragrance (75)
- Preservatives (81)
- Repair (101)
- Rheology/Viscosity Modifier (93)
- Surfactant/Emulsifier (141)
- UV Filter (118)
Build a solid foundation in science, formulation and product development—find out more!
Most Popular in:
Cosmetic Peptides and Consumer Communication: A Q&A with Lipotec's Cristina Carreño, PhD
By: Katie Anderson
Posted: May 24, 2013
On Apr. 15, 2013, experts from Lipotec (acquired by The Lubrizol Corporation in 2012) appeared on Lifetime Television's The Balancing Act to talk about anti-aging skin care, with particular attention to the company's innovative peptides.
Lipotec's Raquel Delgado, PhD, chief innovation officer; and Cristina Carreño, PhD, director of business development, discussed the company's innovations and offered advice to consumers looking for efficacious anti-aging skin care. Although this video can be viewed online, Cosmetics & Toiletries sat down with Carreño at Suppliers' Day 2013 to talk more about peptides, advances in anti-aging skin care and ways for suppliers and manufacturers alike to better communicate skin care science to the consumer.
C&T: How was Lipotec chosen to discuss anti-aging skin care technology on the Balancing Act?
CC: They wanted to communicate the technology behind cosmetics, and they felt that we were the right partner to talk about that technology. Lipotec is known in the industry for our peptides; we were one of the first players in the industry for peptides, starting in the 2000s. The Balancing Act approached us to talk about this subject, and we were excited for the opportunity to help tell our story.
C&T: How has the peptides market changed since Lipotec first became a player?
CC: When our peptides were first introduced, it was a novel approach to skin care based on real science and developed following a similar strategy used in the pharmaceutical industry. At that time, peptide were mainly used for anti-wrinkle purposes. Now, there are peptides for a variety of different targets such as scalp treatment, sagging, DNA repair, etc.
C&T: How does Lipotec identify novel peptides?
CC: We first identify the biological pathways that play a role in a cosmetic need. We invest a lot of effort in R&D. Of the 100 people in the company, 40 are in R&D from all scientific backgrounds. Once the pathway is identified, we can investigate a material that modulates that pathway.